skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,360  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Material Type:
Article
Add to My Research

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease

Vascular health and risk management, 2016-01, Vol.12 (Issue 1), p.171-183 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Toth. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S104369 ;PMID: 27226718

Full text available

2
A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
Material Type:
Article
Add to My Research

A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?

Vascular health and risk management, 2023-01, Vol.19, p.237-253 [Peer Reviewed Journal]

2023 Diab et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Diab et al. 2023 Diab et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S379874 ;PMID: 37113563

Full text available

3
A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
Material Type:
Article
Add to My Research

A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease

Vascular health and risk management, 2016-01, Vol.12 (Issue 1), p.85-103 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Maeder et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S74703 ;PMID: 27051291

Full text available

4
Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis

Drug design, development and therapy, 2018-01, Vol.12, p.1685-1695 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Liu et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S166893 ;PMID: 29928112

Full text available

5
Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies
Material Type:
Article
Add to My Research

Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies

Vascular health and risk management, 2021-01, Vol.17, p.527-542 [Peer Reviewed Journal]

2021 Handhle et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Handhle et al. 2021 Handhle et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S266244 ;PMID: 34526771

Full text available

6
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review
Material Type:
Article
Add to My Research

Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review

Vascular health and risk management, 2024-01, Vol.20, p.215-229 [Peer Reviewed Journal]

2024 Mehta et al. ;2024 Mehta et al. 2024 Mehta et al. ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S464471 ;PMID: 38745849

Full text available

7
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
Material Type:
Article
Add to My Research

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance

Vascular health and risk management, 2017-01, Vol.13, p.293-303 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Aghel et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s108874 ;PMID: 28831263

Full text available

8
Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action
Material Type:
Article
Add to My Research

Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action

Vascular health and risk management, 2021-01, Vol.17, p.739-769 [Peer Reviewed Journal]

2021 Zuraini et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 Zuraini et al. 2021 Zuraini et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S328096 ;PMID: 34858028

Full text available

9
Nonadherence to statins: individualized intervention strategies outside the pill box
Material Type:
Article
Add to My Research

Nonadherence to statins: individualized intervention strategies outside the pill box

Vascular health and risk management, 2018-01, Vol.14, p.91-102 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018 Lansberg et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S158641 ;PMID: 29872306

Full text available

10
Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care
Material Type:
Article
Add to My Research

Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care

Vascular health and risk management, 2020-01, Vol.16, p.11-25 [Peer Reviewed Journal]

2020 Alonso et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Alonso et al. 2020 Alonso et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S192401 ;PMID: 32021224

Full text available

11
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes
Material Type:
Article
Add to My Research

Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes

Vascular health and risk management, 2013-01, Vol.9 (default), p.617-670 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Kones. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2013 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S37119 ;PMID: 24174878

Full text available

12
Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
Material Type:
Article
Add to My Research

Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases

International journal of nanomedicine, 2020-01, Vol.15, p.3741-3769 [Peer Reviewed Journal]

2020 Pala et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Pala et al. 2020 Pala et al. ;ISSN: 1178-2013 ;ISSN: 1176-9114 ;EISSN: 1178-2013 ;DOI: 10.2147/IJN.S250872 ;PMID: 32547026

Full text available

13
How To Support Smoking Cessation In Primary Care And The Community: A Systematic Review Of Interventions For The Prevention Of Cardiovascular Diseases
Material Type:
Article
Add to My Research

How To Support Smoking Cessation In Primary Care And The Community: A Systematic Review Of Interventions For The Prevention Of Cardiovascular Diseases

Vascular health and risk management, 2019-01, Vol.15, p.485-502 [Peer Reviewed Journal]

2019 Odorico et al. ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Odorico et al. 2019 Odorico et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s221744 ;PMID: 31802882

Full text available

14
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date
Material Type:
Article
Add to My Research

Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date

Vascular health and risk management, 2020-01, Vol.16, p.1-10 [Peer Reviewed Journal]

2020 Jia et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Jia et al. 2020 Jia et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S210149 ;PMID: 32021223

Full text available

15
Subclinical Vascular Damage: Current Insights and Future Potential
Material Type:
Article
Add to My Research

Subclinical Vascular Damage: Current Insights and Future Potential

Vascular health and risk management, 2021-01, Vol.17, p.729-738 [Peer Reviewed Journal]

2021 Mattioli et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Mattioli et al. 2021 Mattioli et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S242636 ;PMID: 34866906

Full text available

16
Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
Material Type:
Article
Add to My Research

Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data

Vascular health and risk management, 2021, Vol.17, p.497-508 [Peer Reviewed Journal]

2021 Alwani et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Alwani et al. 2021 Alwani et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S309714 ;PMID: 34465997

Full text available

17
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study
Material Type:
Article
Add to My Research

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study

Vascular health and risk management, 2016-01, Vol.12 (Issue 1), p.251-261 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Haider et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S108947 ;PMID: 27366080

Full text available

18
Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review
Material Type:
Article
Add to My Research

Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review

Vascular health and risk management, 2020-01, Vol.16, p.149-155 [Peer Reviewed Journal]

2020 Watanabe and Kotani. ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Watanabe and Kotani. 2020 Watanabe and Kotani. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s245829 ;PMID: 32368073

Full text available

19
Cardiovascular co-morbidity in rheumatic diseases
Material Type:
Article
Add to My Research

Cardiovascular co-morbidity in rheumatic diseases

Vascular health and risk management, 2008, Vol.4 (3), p.605-614 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Turesson et al, publisher and licensee Dove Medical Press Ltd 2008 ;ISSN: 1176-6344 ;ISSN: 1178-2048 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S2453 ;PMID: 18827910

Full text available

20
Possible Clinical Benefits of Cardio-Ankle Vascular Index Measurement in Urological Diseases
Material Type:
Article
Add to My Research

Possible Clinical Benefits of Cardio-Ankle Vascular Index Measurement in Urological Diseases

Vascular health and risk management, 2023-01, Vol.19, p.127-132 [Peer Reviewed Journal]

2023 Bulbul et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Bulbul et al. 2023 Bulbul et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S384937 ;PMID: 36923496

Full text available

Results 1 - 20 of 1,360  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait